Richter SyndromeSymptoms, Doctors, Treatments, Advances & More
Richter Syndrome Overview
Learn About Richter Syndrome
- Richter syndrome
- Richter transformation
Providence Regional Cancer System - Aberdeen
Dr. Sui earned a medical degree from Qingdao University, China, and a Ph.D. from the University of Tokyo, Japan. He conducted postdoctoral research in hematology at Vanderbilt University, an internal medicine residency at the University of Tennessee, and a medical oncology fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington. He is board certified in internal medicine and medical oncology. He was an associate professor at Shangdong. Dr. Sui believes in treating his patients as if they were his own family members. Dr. Sui is rated as a Distinguished provider by MediFind in the treatment of Richter Syndrome. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Pleuropulmonary Blastoma, and Large-Cell Immunoblastic Lymphoma. Dr. Sui is board certified in American Board Of Internal Medicine. Dr. Sui is currently accepting new patients.
Chronic Lymphocytic Leukemia (CLL)
Richard Furman is an Oncologist practicing medicine in New York, New York. Dr. Furman is rated as an Elite provider by MediFind in the treatment of Richter Syndrome. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy. Dr. Furman is currently accepting new patients.
Francesco Forconi practices practicing medicine in Southampton, United Kingdom. Mr. Forconi is rated as an Elite expert by MediFind in the treatment of Richter Syndrome. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Hairy Cell Leukemia (HCL).
Summary: This is a national clinical trial, multicentric (28 centers), non-randomized phase 2 study. Population: Patients with previously untreated Richter's syndrome (RS), defined as the occurrence of an aggressive lymphoma (of diffuse large B-cell lymphoma histology) in a patient with chronic lymphocytic leukemia (CLL). Study treatment: The duration of each cycle is 21 days. Cycle 1: Participants will re...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


